Vanderbilt researchers hope their new method to describe cells will be widely adopted and used to generate a “Who’s Who” database of cell types.

The protein beta-catenin may be a good target for therapies to treat lung disease that is a common complication of preterm birth.

A signaling protein overexpressed in upper gastrointestinal cancers is an attractive therapeutic target.

Josep Dalmau, M.D., Ph.D., renowned for his studies of immune disorders affecting the brain and spinal cord, will deliver the next Flexner Discovery Lecture on Thursday, Feb. 23.

The signaling molecule IL-15 promotes septic shock, a life-threatening condition involving organ injury caused by infection.

Vanderbilt researchers have identified a unique example of communication between bacterial signaling systems, which may have relevance for antibiotic resistance.